Table 2. Univariate analysis of prognostic factors for overall survival and recurrence-free survival in 121 patients with basaloid squamous cell carcinoma of the esophagus.

		Overall Survival		Recurrence-free Survival
		Median(mon)	P value	Median(mon)	P value
Age(yr)	≤60	38.0	0.463	26.0	0.750
	>60	32.0		23.0
Gender	Male	38.0	0.195	23.0	0.224
	Female	26.0		18.0
Weight loss	Yes	42.0	0.002	27.0	0.005
	No	24.0		7.0
Tumor location	Upper	27.0	0.589	24.0	0.5
	Middle	35.0		18.0
	Lower	38.0		26.0
Tumor length	≤4.25	59.0	0.003	44.0	<0.001
(cm)	>4.25	26.0		10.0
Pathological T	T1/2	51.0	0.008	39.0	0.006
stage	T3/4	28.0		15.0
Pathological N	N-	43.0	0.001	27.0	0.008
stage	N+	24.0		14.0
Pathological	I	NR	<0.001	NR	<0.001
TNM stage	II	38.0		22.0
	III	23.0		9.0
Lymphocyte	≤2.13	38.0	0.584	25.0	0.511
count (×109/L)	>2.13	36.0		21.0
Neutrophil	≤3.74	42.0	0.181	27.0	0.097
count (×109/L)	>3.74	32.0		18.0
Monocyte	≤0.27	32.0	0.387	21.0	0.870
count (×109/L)	>0.27	38.0		24.0
NMR	≤12.31	43.0	0.042	27.0	0.149
	> 12.31	31.0		18.0
NLR	≤1.77	51.0	0.008	44.0	0.002
	> 1.77	31.0		14.0
Albumin (g/L)	≤40.0	26.0	0.024	12.0	0.115
	> 40.0	42.0		27.0

NMR: neutrophil-to-monocyte ratio; NLR: neutrophil-to-lymphocyte ratio; NR: not reached.